David Fishman, MD

Publications

139

1 grant

PI
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers
NCI · 2022–2026 · via NIH RePORTER
R01CA260399-05

Completed grants (3)

PI
Microvascular Perfusion Sonographic Imaging to Detect Early Stage Ovarian Cancer
NCI · 2007–2011 · via NIH RePORTER
R21CA125227-03
PI
THE NATIONAL OVARIAN CANCER EARLY DETECTION PROGRAM
NCI · 1999–2005 · via NIH RePORTER
No publications yet
U01CA085133-05
PI
New Frontiers in Cancer Detection and Diagnosis
NCI · 2002–2003 · via NIH RePORTER
R13CA095601-01

Completed & closed trials (3)

PI
A Phase 3 Study of Relacorilant in Combination With Nab-Paclitaxel Versus Nab-Paclitaxel Monotherapy in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer (ROSELLA)
PHASE3 · Corcept Therapeutics Incorporated · CLOSED TO ACCRUAL (as of 2024)
Ovarian Neoplasm; Fallopian Tube Neoplasms; Peritoneal Neoplasms
NCT05257408
PI
Functional Protein Signaling Pathway Activation in Advanced Stage ER+/Her2- Breast and Serous Ovarian Cancers
Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2023)
PI
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
PHASE3 · Seagen Inc. · IRB STUDY CLOSURE (as of 2022)
Cervical Cancer
NCT04697628